426 related articles for article (PubMed ID: 23745991)
1. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.
Ryan JL; Heckler CE; Ling M; Katz A; Williams JP; Pentland AP; Morrow GR
Radiat Res; 2013 Jul; 180(1):34-43. PubMed ID: 23745991
[TBL] [Abstract][Full Text] [Related]
2. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.
Ryan Wolf J; Heckler CE; Guido JJ; Peoples AR; Gewandter JS; Ling M; Vinciguerra VP; Anderson T; Evans L; Wade J; Pentland AP; Morrow GR
Support Care Cancer; 2018 May; 26(5):1543-1552. PubMed ID: 29192329
[TBL] [Abstract][Full Text] [Related]
3. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
[TBL] [Abstract][Full Text] [Related]
4. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
5. Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.
Ryan Wolf J; Gewandter JS; Bautista J; Heckler CE; Strasser J; Dyk P; Anderson T; Gross H; Speer T; Dolohanty L; Bylund K; Pentland AP; Morrow GR
Support Care Cancer; 2020 Jul; 28(7):3303-3311. PubMed ID: 31758326
[TBL] [Abstract][Full Text] [Related]
6. The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Sahin F; Pirouzpanah MB; Bijanpour H; Mohammadzadeh M; Eghdam Zamiri R; Ghasemi Jangjoo A; Nasiri B; Saboori H; Doğan A; Demirci S; Ayşan E; Çağrı Büke A; Naseri AR; Shakouri SK; Aghamohammadi D; Alizade-Harakiyan M; Seyed Nejad F
Oncol Res Treat; 2022; 45(4):197-204. PubMed ID: 34979503
[TBL] [Abstract][Full Text] [Related]
7. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
8. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
9. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
10. Impact of Curcumin Supplementation on Radiation Dermatitis Severity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Mirzaei Dahka S; Afsharfar M; Tajaddod S; Sohouli MH; Shekari S; Bakhshi Nafouti F; Alizadeh A; Shafahi Kachaei H; Abbasi K; Khalatbari Mohseni G; Alami F; Gholamalizadeh M; Doaei S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):783-789. PubMed ID: 36974529
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
12. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
14. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
15. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
16. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.
Meghrajani CF; Co HS; Arcillas JG; Maaño CC; Cupino NA
Expert Rev Clin Pharmacol; 2016; 9(3):483-91. PubMed ID: 26619355
[TBL] [Abstract][Full Text] [Related]
18. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Acceptability of a Moisturizing Cream and a Barrier Cream During Radiation Therapy for Breast Cancer in the Tropics: A Randomized Controlled Trial.
Laffin N; Smyth W; Heyer E; Fasugba O; Abernethy G; Gardner A
Cancer Nurs; 2015; 38(3):205-14. PubMed ID: 24945268
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]